(Million Yen)

Shareholders' equity

FY2023

(3/2024)

FY2024

(3/2025)

FY2025

(3/2026)

Share capital

Balance at beginning of period

2,514

2,514

2,514

Total Changes during period

Balance at end of period

2,514

2,514

2,514

Capital surplus

Balance at beginning of period

3,403

2,979

2,979

Changes during period

Disposal of treasury shares

18

27

28

Cancellation of treasury shares

(1,294)

(1,294)

Transfer from retained earnings to capital surplus

852

1,267

Purchase of shares of consolidated subsidiaries

Total Changes during period

(424)

28

Balance at end of period

2,979

2,979

3,008

Retained earnings

Balance at beginning of period

19,105

20,897

22,696

Changes during period

Dividends of surplus

(1,083)

(1,339)

(2,123)

Profit attributable to owners of parent

3,728

4,405

5,279

Transfer from retained earnings to capital surplus

(852)

(1,267)

Change of scope of equity method

Total Changes during period

1,792

1,799

3,155

Balance at end of period

20,897

22,696

25,852

Treasury shares

Balance at beginning of period

(2,150)

(1,813)

(491)

Changes during period

Purchase of treasury shares

(995)

0

(1,499)

Disposal of treasury shares

38

27

73

Cancellation of treasury shares

1,294

1,294

Total Changes during period

337

1,321

(1,425)

Balance at end of period

(1,813)

(491)

(1,917)

Total shareholders' equity

Balance at beginning of period

22,873

24,579

27,699

Changes during period

Dividends of surplus

(1,083)

(1,339)

(2,123)

Profit attributable to owners of parent

3,728

4,405

5,279

Purchase of treasury shares

(995)

(1,499)

Disposal of treasury shares

56

54

102

Cancellation of treasury shares

Change of scope of equity method

Purchase of shares of consolidated subsidiaries

Total Changes during period

1,705

3,120

1,758

Balance at end of period

24,579

27,699

29,458

Accumulated other comprehensive income

FY2023

(3/2024)

FY2024

(3/2025)

FY2025

(3/2026)

Valuation difference on available-forsale securities

Balance at beginning of period

1,488

2,920

2,986

Changes during period

Net changes in items other than shareholders’ equity

1,431

65

854

Total Changes during period

1,431

65

854

Balance at end of period

2,920

2,986

3,840

Foreign currency translation adjustment

Balance at beginning of period

18

26

20

Changes during period

Net changes in items other than shareholders’ equity

8

(5)

4

Total Changes during period

8

(5)

4

Balance at end of period

26

20

24

Remeasurements of defined benefit plans

Balance at beginning of period

69

155

108

Changes during period

Net changes in items other than shareholders’ equity

85

(46)

46

Total Changes during period

85

(46)

46

Balance at end of period

155

108

154

Total accumulated other comprehensive income

Balance at beginning of period

1,576

3,102

3,115

Changes during period

Net changes in items other than shareholders’ equity

1,525

13

904

Total Changes during period

1,525

13

904

Balance at end of period

3,102

3,115

4,020

Subscription rights to shares

FY2023

(3/2024)

FY2024

(3/2025)

FY2025

(3/2026)

Balance at beginning of period

Changes during period

Net changes in items other than shareholders’ equity

Total Changes during period

Balance at end of period

Total net assets

FY2023

(3/2024)

FY2024

(3/2025)

FY2025

(3/2026)

Balance at beginning of period

24,449

27,681

30,815

Changes during period

Dividends of surplus

(1,083)

(1,339)

(2,123)

Profit attributable to owners of parent

3,728

4,405

5,279

Purchase of treasury shares

(995)

(1,499)

Disposal of treasury shares

56

54

102

Cancellation of treasury shares

Change of scope of equity method

Purchase of shares of consolidated subsidiaries

Net changes in items other than shareholders’ equity

1,525

13

904

Total Changes during period

3,231

3,134

2,663

Balance at end of period

27,681

30,815

33,479